89 related articles for article (PubMed ID: 22120430)
1. Validation of an immunohistochemical signature predictive of 8-year outcome for patients with breast carcinoma.
Charpin C; Tavassoli F; Secq V; Giusiano S; Villeret J; Garcia S; Birnbaum D; Bonnier P; Lavaut MN; Boubli L; Carcopino X; Iovanna J
Int J Cancer; 2012 Aug; 131(3):E236-43. PubMed ID: 22120430
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk.
Giusiano S; Secq V; Carcopino X; Carpentier S; Andrac L; Lavaut MN; Allasia C; Bonnier P; Iovanna JL; Garcia S; Boubli L; Birnbaum D; Charpin C
Int J Oncol; 2010 Apr; 36(4):889-98. PubMed ID: 20198333
[TBL] [Abstract][Full Text] [Related]
3. Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma.
Ni W; Yang Z; Qi W; Cui C; Cui Y; Xuan Y
Hum Pathol; 2017 Nov; 69():38-45. PubMed ID: 28965964
[TBL] [Abstract][Full Text] [Related]
4. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarrays.
Giusiano S; Cochet C; Filhol O; Duchemin-Pelletier E; Secq V; Bonnier P; Carcopino X; Boubli L; Birnbaum D; Garcia S; Iovanna J; Charpin C
Eur J Cancer; 2011 Mar; 47(5):792-801. PubMed ID: 21194925
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1→HIF-1α pathway.
Argyriou P; Papageorgiou SG; Panteleon V; Psyrri A; Bakou V; Pappa V; Spathis A; Economopoulou P; Papageorgiou E; Economopoulos T; Rontogianni D
Ann Hematol; 2011 Mar; 90(3):315-22. PubMed ID: 20838824
[TBL] [Abstract][Full Text] [Related]
7. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced factor-1 alpha, vascular endothelial growth factor expression in BRCA1-related breast cancer: A prospective study in tertiary care hospital.
Sharma M; Piplani S; Madan M; Manjari M; Garg S; Kaur K
Indian J Pathol Microbiol; 2017; 60(4):469-474. PubMed ID: 29323057
[TBL] [Abstract][Full Text] [Related]
9. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype.
Garcia S; Dalès JP; Charafe-Jauffret E; Carpentier-Meunier S; Andrac-Meyer L; Jacquemier J; Andonian C; Lavaut MN; Allasia C; Bonnier P; Charpin C
Hum Pathol; 2007 Jun; 38(6):830-41. PubMed ID: 17316758
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.
Capodanno A; Camerini A; Orlandini C; Baldini E; Resta ML; Bevilacqua G; Collecchi P
Hum Pathol; 2009 Oct; 40(10):1408-17. PubMed ID: 19428048
[TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients.
Dales JP; Garcia S; Meunier-Carpentier S; Andrac-Meyer L; Haddad O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Cancer; 2005 Sep; 116(5):734-9. PubMed ID: 15849727
[TBL] [Abstract][Full Text] [Related]
13. BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters.
Madaras L; Balint N; Gyorffy B; Tokes AM; Barshack I; Yosepovich A; Friedman E; Paluch-Shimon S; Zippel D; Baghy K; Timar J; Kovalszky I; Kulka J; Szasz AM
Pathobiology; 2016; 83(1):1-12. PubMed ID: 26566278
[TBL] [Abstract][Full Text] [Related]
14. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases.
Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL
Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
Kronblad A; Jirström K; Rydén L; Nordenskjöld B; Landberg G
Int J Cancer; 2006 May; 118(10):2609-16. PubMed ID: 16381002
[TBL] [Abstract][Full Text] [Related]
16. Predictive and prognostic significance of p27, Akt, PTEN and PI3K expression in HER2-positive metastatic breast cancer.
Okutur K; Bassulu N; Dalar L; Aydin K; Bozkurt M; Pilanci KN; Dogusoy GB; Tecimer C; Mandel NM; Demir G
Asian Pac J Cancer Prev; 2015; 16(7):2645-51. PubMed ID: 25854340
[TBL] [Abstract][Full Text] [Related]
17. Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer.
Qin R; Smyrk TC; Reed NR; Schmidt RL; Schnelldorfer T; Chari ST; Petersen GM; Tang AH
Br J Cancer; 2015 Feb; 112(3):514-22. PubMed ID: 25584484
[TBL] [Abstract][Full Text] [Related]
18. A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays.
Charpin C; Secq V; Giusiano S; Carpentier S; Andrac L; Lavaut MN; Allasia C; Bonnier P; Garcia S
Int J Cancer; 2009 May; 124(9):2124-34. PubMed ID: 19142869
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of hypoxia-inducible factor 1α, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma.
Feng Z; Gan H; Cai Z; Li N; Yang Z; Lu G; Chen J
Jpn J Clin Oncol; 2013 Apr; 43(4):396-403. PubMed ID: 23372184
[TBL] [Abstract][Full Text] [Related]
20. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
